Effect on Infant Illness of Maternal Supplementation With 400000 IU Vs 200000 IU of Vitamin A
Dos Santos Fernandes TF et al. – These findings suggest that postpartum maternal supplementation with 400000 IU of vitamin A does not provide any additional benefits in the reduction of illness in children aged <6 months; therefore, they do not support the proposal to increase the standard vitamin A dose in the existing WHO protocol.
This was a randomized controlled, triple-blinded clinical trial conducted at 2 public maternity hospitals in Recife in northeastern Brazil.
There were 276 mother–child pairs that were allocated to 2 treatment groups: 400000 IU or 200000 IU of vitamin A.
They were followed up for >6 months to evaluate infant morbidity.
Fever (rate ratio [RR]: 0.92 [95% confidence interval (CI): 0.75–1.14]), diarrhea (RR: 0.96 [95% CI: 0.72–1.28]), otitis (RR: 0.94 [95% CI: 0.48–1.85]), acute respiratory infection (RR: 1.03 [95% CI: 0.88–1.21]), the need for intravenous rehydration (RR: 2.08 [95% CI: 0.64–2.07]), and the use of antibiotic treatment (RR: 0.80 [95% CI: 0.43–1.47]) did not differ significantly between the 2 treatment groups.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.